Skip to main content
Veterinary Medicines

REMUVET 100 MG/500 MG SPOT-ON SOLUTION FOR DOGS OVER 4 KG UP TO 10 KG

Authorised
  • Imidacloprid
  • Permethrin

Product identification

Medicine name:
REMUVET 100 MG/500 MG SPOT-ON SOLUTION FOR DOGS OVER 4 KG UP TO 10 KG
REMUVET 100 mg/500 mg SOLUCION SPOT-ON PARA PERROS DE MAS DE 4 Kg HASTA 10 Kg
Active substance:
  • Imidacloprid
  • Permethrin
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    100.00
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin
    500.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Pack containing 1 PET/PE/aluminium/surlyn sachet containing one white polypropylene unit dose pipette
  • Pack containing 2 PET/PE/aluminium/surlyn sachets each containing one white polypropylene unit dose pipette
  • Pack containing 3 PET/PE/aluminium/surlyn sachets each containing one white polypropylene unit dose pipette
  • Pack containing 4 PET/PE/aluminium/surlyn sachets each containing one white polypropylene unit dose pipette
  • Pack containing 6 PET/PE/aluminium/surlyn sachets each containing one white polypropylene unit dose pipette
  • Pack containing 12 PET/PE/aluminium/surlyn sachets each containing one white polypropylene unit dose pipette
  • Pack containing 24 PET/PE/aluminium/surlyn sachets each containing one white polypropylene unit dose pipette

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Beaphar B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Beaphar B.V.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 4285 ESP
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0440/002
Concerned member states:
  • Italy
  • Portugal
  • Spain